New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 24, 2025 - The FDA approved Sebela Women’s Health’s Miudella (copper intrauterine system), for prevention of pregnancy in females of reproductive potential for up to 3 years.
Download PDF
Return to publications
